Kaiyuan securities maintains Winner Medical Co.Ltd(300888) buy rating: the high base of the medical sector has exceeded the expectation, and the performance will grow steadily in 2022

After AI express, Kaiyuan securities released a research report on April 24, saying that it maintained the buying rating of Winner Medical Co.Ltd(300888) ( Winner Medical Co.Ltd(300888) . SZ, latest price: 58.6 yuan). The reasons for rating mainly include: 1) the revenue in 2021 improved quarter by quarter, and the profit in 2022q1 was still under short-term pressure, maintaining the “buy” rating; 2) Medical consumables: expand the channel width and jointly build a high-end wound dressing faucet with Longtai; 3) Consumer goods for healthy living: the growth rate of textile products is bright, and the self owned e-commerce platform maintains rapid growth; 4) The profitability is higher than the level before the epidemic, and the strategic stock is prepared to cope with the price rise of raw materials. Risk tip: downstream market demand fluctuates, customer development is less than expected, and raw material prices and exchange rates fluctuate.

AI comments: Winner Medical Co.Ltd(300888) has received 16 research reports from securities companies in the past month, including 13 purchases and 3 holdings. The average target price is 64.97 yuan, which is 6.37 yuan higher than the latest price of 58.6 yuan, and the average target price increases by 10.87%.

- Advertisment -